KIMBERLY EDWARDS MCLEAN: Open Payments
NPI 1285240010 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| GENZYME CORPORATION | 1 | $36 |
| Genentech USA, Inc. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $23 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $18 |
| Legend Biotech USA Inc. | 1 | $14 |
Products named: SARCLISA, NINLARO, Venclexta, Quzyttir, FOTIVDA, CLOSUREFAST, CARVYKTI, FRUZAQLA.
Industry payments across GA — which companies pay providers there.
